0108 Gracell IPO
BioCentury & Getty Images


Gracell looks to NASDAQ IPO to place it among CAR T leaders

Suzhou company shines in first day of trading after raising more than $200M

Suzhou-based Gracell Biotechnologies hopes its listing on the U.S. exchange will put it on the map as a global player in CAR T therapies.

Jan 9, 2021 | 5:00 AM GMT

Gracell has

Read the full 615 word article

How to gain access

Continue reading with a
two-week free trial.